ADVFN ADVFN

Hot Features

Icon for default Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
Sonoma Pharmaceuticals Inc

Sonoma Pharmaceuticals Inc (SNOA)

1,09
-0,05
(-4,39%)
Fermé 09 Juin 10:00PM
1,07
-0,02
(-1,83%)
Après les heures de négociation: 1:56AM

Sonoma Pharmaceuticals Inc (SNOA) Action

Outils de qualité professionnelle, pour des investisseurs individuels.

Premium

Statistiques et détails clés

Dernier
1,07
( -6,14% )
Prix Achat
1,04
Prix Vente
1,14
Volume échangé
91 490
1,095 Fourchette du Jour 1,16
0,8501 Plage de 52 semaines 6,9199
Cap du marché
Clôture Veille
1,14
Ouverture
1,15
Dernière Transaction
1
@
1.0704
Dernière heure de transaction
Volume financier
US$ 102 851
VWAP
1,1242
Volume moyen (3 m)
US$ 194 129
Actions en circulation
3 473 554
Rendement du Dividende (LTM)
Ratio Cours sur Bénéfices
-0,56
Bénéfice par action (BPA)
-2,04
Chiffre d'affairess (LTM)
17,72M
Bénéfice net (LTM)
-3,37M

À propos de Sonoma Pharmaceuticals Inc

Sonoma Pharmaceuticals, Inc. develops and produces stabilized hypochlorous acid (HOCl) products for wound and eye care, oral and nasal care, podiatry, animal health care, and dermatological conditions in the United States, Europe, Asia, Latin America, and internationally. It offers Lumacyn, a skin t... Sonoma Pharmaceuticals, Inc. develops and produces stabilized hypochlorous acid (HOCl) products for wound and eye care, oral and nasal care, podiatry, animal health care, and dermatological conditions in the United States, Europe, Asia, Latin America, and internationally. It offers Lumacyn, a skin toner; Regenacyn, a prescription scar gel; Reliefacyn to alleviate red bumps, rashes, shallow skin fisures, sunburn, peeling, and eczema/atopic dermatitis; Gramaderm for the treatment of topical mild to moderate acne; Epicyn, an antimicrobial facial cleanser; Levicyn, an HOCl based prescription and over-the-counter product used to relieve skin irritations, lacerations, abrasions, and burns; Celacyn, a scar management gel; and Pediacyn, an atopic dermatitis hydrogel. The company also provides Microcyn, a HOCl-based topical line of products designed to stimulate expedited healing by targeting a range of pathogens; Ocucyn eyelid and eyelash cleanser; Ocudox for eye care; Sinudox for nasal irrigation; Microdacyn60 oral care solution to treat mouth and throat infections; and Podiacyn, a foot care product. In addition, it offers MicrocynAH, an HOCl-based solution used to relieve common symptoms of hot spots, scratches, skin rashes, post-surgical sites, and irritated animal skin; MicrocynVS, an animal care product; Nanocyn, a hospital-grade disinfectant; Acuicyn, a solution for the treatment of blepharitis and the daily hygiene of eyelids and lashes; MucoClyns, a disinfectant; and Endocyn, a root canal irrigation solution. The company was formerly known as Oculus Innovative Sciences, Inc. and changed its name to Sonoma Pharmaceuticals, Inc. in December 2016. Sonoma Pharmaceuticals, Inc. was incorporated in 1999 and is based in Boulder, Colorado. Show more

Secteur
Healthcare
Industrie
Pharmaceuticals
Site Web
Siège social
Boulder, United States
Fondé
1999
Sonoma Pharmaceuticals Inc est coté dans le secteur Healthcare de la NASDAQ avec le ticker SNOA. Le dernier cours de clôture d'Sonoma Pharmaceuticals était de US$1,14. Au cours de la dernière année, les actions de Sonoma Pharmaceuticals ont été négociées dans une fourchette de prix de US$ 0,8501 à US$ 6,9199.

Sonoma Pharmaceuticals compte actuellement 3 473 554 actions en circulation. La capitalisation boursière d'Sonoma Pharmaceuticals est de US$3,72 million. Sonoma Pharmaceuticals a un ratio cours/bénéfice (ratio PE) de -0.56.

SNOA Dernières nouvelles

PériodeVariationVariation %Ouver.HautBasMoyenne Vol. Quot.VWAP
1-0.08-6.956521739131.151.291.071419821.18767387CS
4-0.12-10.08403361341.191.2911383631.11250201CS
12-1.38-56.32653061222.452.880.85012092331.34540824CS
26-2.46-69.68838526913.533.950.85011077281.52032285CS
52-2.29-68.15476190483.366.91990.85013864864.55632234CS
1560.157717.28598048890.91236.91990.115911662971.43487853CS
260-6.69-86.21134020627.7613.360.115910747462.59328605CS

SNOA - Frequently Asked Questions (FAQ)

What is the current Sonoma Pharmaceuticals Inc share price?
The current share price of Sonoma Pharmaceuticals Inc is US$ 1,07
How many Sonoma Pharmaceuticals Inc shares are in issue?
Sonoma Pharmaceuticals Inc has 3 473 554 shares in issue
What is the market cap of Sonoma Pharmaceuticals Inc?
The market capitalisation of Sonoma Pharmaceuticals Inc is USD 3,72M
What is the 1 year trading range for Sonoma Pharmaceuticals Inc share price?
Sonoma Pharmaceuticals Inc has traded in the range of US$ 0,8501 to US$ 6,9199 during the past year
What is the PE ratio of Sonoma Pharmaceuticals Inc?
The price to earnings ratio of Sonoma Pharmaceuticals Inc is -0,56
What is the cash to sales ratio of Sonoma Pharmaceuticals Inc?
The cash to sales ratio of Sonoma Pharmaceuticals Inc is 0,22
What is the registered address of Sonoma Pharmaceuticals Inc?
The registered address for Sonoma Pharmaceuticals Inc is 5445 Conestoga Court, Boulder, Colorado, 80301
What is the Sonoma Pharmaceuticals Inc website address?
The website address for Sonoma Pharmaceuticals Inc is sonomapharma.com
Which industry sector does Sonoma Pharmaceuticals Inc operate in?
Sonoma Pharmaceuticals Inc operates in the Pharmaceuticals sector

SNOA Transactions

Plus

Transactions différées

Pour obtenir des transactions en temps réel, améliorez votre compte

Passer à la version en temps réel
Aucune Discussion Trouvée
Ajouter une Discussion

Dernières Valeurs Consultées

Delayed Upgrade Clock